West Pharmaceutical Services Stock Analysis
WST Stock | USD 377.33 0.03 0.01% |
West Pharmaceutical Services is fairly valued with Real Value of 390.02 and Target Price of 400.71. The main objective of West Pharmaceutical stock analysis is to determine its intrinsic value, which is an estimate of what West Pharmaceutical Services is worth, separate from its market price. There are two main types of West Pharmaceutical's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect West Pharmaceutical's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of West Pharmaceutical's stock to identify patterns and trends that may indicate its future price movements.
The West Pharmaceutical stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. West Pharmaceutical is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. West Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and West Pharmaceutical's ongoing operational relationships across important fundamental and technical indicators.
West |
West Stock Analysis Notes
About 96.0% of the company outstanding shares are owned by institutional investors. The company recorded earning per share (EPS) of 7.89. West Pharmaceutical last dividend was issued on the 23rd of April 2024. The entity had 2:1 split on the 27th of September 2013. West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania. West Pharmaceutical operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 10065 people. For more information please call Eric Green at 610 594 2900 or visit https://www.westpharma.com.West Pharmaceutical Quarterly Total Revenue |
|
West Pharmaceutical Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. West Pharmaceutical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding West Pharmaceutical Services or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
West Pharmaceutical is unlikely to experience financial distress in the next 2 years | |
West Pharmaceutical has a strong financial position based on the latest SEC filings | |
Over 96.0% of the company outstanding shares are owned by institutional investors | |
Latest headline from finance.yahoo.com: West Pharmaceutical Services Expected to Beat Earnings Estimates Should You Buy |
West Pharmaceutical Upcoming and Recent Events
Earnings reports are used by West Pharmaceutical to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to West Pharmaceutical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
15th of February 2024 Upcoming Quarterly Report | View | |
25th of April 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
15th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
West Largest EPS Surprises
Earnings surprises can significantly impact West Pharmaceutical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2004-10-19 | 2004-09-30 | 0.1 | 0.11 | 0.01 | 10 | ||
2003-10-21 | 2003-09-30 | 0.09 | 0.08 | -0.01 | 11 | ||
2002-10-24 | 2002-09-30 | 0.05 | 0.06 | 0.01 | 20 |
West Pharmaceutical Thematic Classifications
In addition to having West Pharmaceutical stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Rubber and Plastic ProductsUSA Equities from Rubber and Plastic Products industry as classified by Fama & French | ||
Obamacare RepealLarge healthcare related equities associated with Obamacare |
West Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as West Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading West Pharmaceutical Services backward and forwards among themselves. West Pharmaceutical's institutional investor refers to the entity that pools money to purchase West Pharmaceutical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | T. Rowe Price Investment Management,inc. | 2023-12-31 | 1.2 M | Durable Capital Partners Lp | 2023-12-31 | 1.1 M | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 1 M | Bamco Inc | 2023-12-31 | 997.8 K | Amvescap Plc. | 2023-12-31 | 942.7 K | Jpmorgan Chase & Co | 2023-12-31 | 880.1 K | Goldman Sachs Group Inc | 2023-12-31 | 868.4 K | Norges Bank | 2023-12-31 | 852.7 K | Northern Trust Corp | 2023-12-31 | 771.6 K | Vanguard Group Inc | 2023-12-31 | 9 M | Blackrock Inc | 2023-12-31 | 7.8 M |
West Market Capitalization
The company currently falls under 'Large-Cap' category with a total capitalization of 27.78 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate West Pharmaceutical's market, we take the total number of its shares issued and multiply it by West Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.West Profitablity
West Pharmaceutical's profitability indicators refer to fundamental financial ratios that showcase West Pharmaceutical's ability to generate income relative to its revenue or operating costs. If, let's say, West Pharmaceutical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, West Pharmaceutical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of West Pharmaceutical's profitability requires more research than a typical breakdown of West Pharmaceutical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of 0.2 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.24 %, which entails that for every 100 dollars of revenue, it generated $0.24 of operating income. Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.16 | 0.17 | |
Return On Capital Employed | 0.21 | 0.22 | |
Return On Assets | 0.15 | 0.16 | |
Return On Equity | 0.21 | 0.22 |
Management Efficiency
West Pharmaceutical has Return on Asset of 0.1193 % which means that on every $100 spent on assets, it made $0.1193 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2132 %, implying that it generated $0.2132 on every 100 dollars invested. West Pharmaceutical's management efficiency ratios could be used to measure how well West Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to 0.17 in 2024. Return On Capital Employed is likely to gain to 0.22 in 2024. At this time, West Pharmaceutical's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 4 B in 2024, despite the fact that Change To Liabilities is likely to grow to (3.1 M).Last Reported | Projected for Next Year | ||
Book Value Per Share | 38.78 | 40.71 | |
Net Current Asset Value | 0.00 | 0.00 | |
Tangible Asset Value | 0.00 | 0.00 | |
Tangible Book Value Per Share | 37.11 | 38.97 | |
Enterprise Value Over EBITDA | 29.25 | 30.72 | |
Price Book Value Ratio | 9.08 | 9.54 | |
Enterprise Value Multiple | 29.25 | 30.72 | |
Price Fair Value | 9.08 | 9.54 | |
Enterprise Value | 374.8 M | 252.4 M |
The analysis of West Pharmaceutical's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze West Pharmaceutical's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of West Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Dividend Yield 0.0021 | Forward Dividend Yield 0.0021 | Forward Dividend Rate 0.8 | Beta 1.025 |
Technical Drivers
As of the 19th of April, West Pharmaceutical maintains the Downside Deviation of 2.74, mean deviation of 1.48, and Market Risk Adjusted Performance of 0.2503. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of West Pharmaceutical Services, as well as the relationship between them. Specifically, you can use this information to find out if the company will indeed mirror its model of past data patterns, or the prices will eventually revert. We are able to interpolate and collect nineteen technical drivers for West Pharmaceutical, which can be compared to its peers. Please check out West Pharmaceutical jensen alpha and semi variance to decide if West Pharmaceutical is priced fairly, providing market reflects its latest price of 377.33 per share. Given that West Pharmaceutical Services has jensen alpha of 0.1145, we strongly advise you to confirm West Pharmaceutical's prevalent market performance to make sure the company can sustain itself at a future point.West Pharmaceutical Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. West Pharmaceutical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for West Pharmaceutical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
West Pharmaceutical Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific West Pharmaceutical insiders, such as employees or executives, is commonly permitted as long as it does not rely on West Pharmaceutical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases West Pharmaceutical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Eric Green over three weeks ago Disposition of 64132 shares by Eric Green of West Pharmaceutical at 359.8511 subject to Rule 16b-3 |
West Pharmaceutical Predictive Daily Indicators
West Pharmaceutical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of West Pharmaceutical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Accumulation Distribution | 6803.94 | |||
Daily Balance Of Power | (0) | |||
Rate Of Daily Change | 1.0 | |||
Day Median Price | 376.52 | |||
Day Typical Price | 376.79 | |||
Price Action Indicator | 0.79 | |||
Period Momentum Indicator | (0.03) |
West Pharmaceutical Corporate Filings
19th of March 2024 Other Reports | ViewVerify | |
13th of March 2024 Other Reports | ViewVerify | |
F4 | 12th of March 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 1st of March 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 29th of February 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 27th of February 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 22nd of February 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10K | 20th of February 2024 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
West Pharmaceutical Forecast Models
West Pharmaceutical's time-series forecasting models are one of many West Pharmaceutical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary West Pharmaceutical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About West Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how West Pharmaceutical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling West shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as West Pharmaceutical. By using and applying West Stock analysis, traders can create a robust methodology for identifying West entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | 0.24 | 0.25 | |
Operating Profit Margin | 0.23 | 0.24 | |
Net Profit Margin | 0.20 | 0.21 | |
Gross Profit Margin | 0.38 | 0.26 |
Current West Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. West analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. West analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
400.71 | Strong Buy | 10 | Odds |
Most West analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand West stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of West Pharmaceutical, talking to its executives and customers, or listening to West conference calls.
West Stock Analysis Indicators
West Pharmaceutical Services stock analysis indicators help investors evaluate how West Pharmaceutical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading West Pharmaceutical shares will generate the highest return on investment. By understating and applying West Pharmaceutical stock analysis, traders can identify West Pharmaceutical position entry and exit signals to maximize returns.
Begin Period Cash Flow | 894.3 M | |
Long Term Debt | 72.8 M | |
Common Stock Shares Outstanding | 75.3 M | |
Total Stockholder Equity | 2.9 B | |
Tax Provision | 122.3 M | |
Quarterly Earnings Growth Y O Y | 0.334 | |
Property Plant And Equipment Net | 1.5 B | |
Cash And Short Term Investments | 853.9 M | |
Cash | 853.9 M | |
Accounts Payable | 242.4 M | |
Net Debt | -544.9 M | |
50 Day M A | 381.4638 | |
Total Current Liabilities | 671.8 M | |
Other Operating Expenses | 2.2 B | |
Non Current Assets Total | 1.9 B | |
Forward Price Earnings | 49.7512 | |
Non Currrent Assets Other | 21.3 M | |
Stock Based Compensation | 23.3 M |
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in West Pharmaceutical Services. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for West Stock analysis
When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Stocks Directory Find actively traded stocks across global markets | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |
Is West Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of West Pharmaceutical. If investors know West will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about West Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.334 | Dividend Share 0.77 | Earnings Share 7.89 | Revenue Per Share 39.701 | Quarterly Revenue Growth 0.033 |
The market value of West Pharmaceutical is measured differently than its book value, which is the value of West that is recorded on the company's balance sheet. Investors also form their own opinion of West Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is West Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because West Pharmaceutical's market value can be influenced by many factors that don't directly affect West Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between West Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if West Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, West Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.